(2008), "Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials", Clinical Governance: An International Journal, Vol. 13 No. 2. https://doi.org/10.1108/cgij.2008.24813bae.011Download as .RIS
Emerald Group Publishing Limited
Copyright © 2008, Emerald Group Publishing Limited
Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials
Article Type: Reviews of effectiveness From: Clinical Governance: An International Journal, Volume 13, Issue 2.
M.E. Falagas, F. Ntziora, G.I. Betsi and G. SamonisInternational Journal of Antimicrobial Agents2007Vol. 29pp. 136-43
This review evaluated the effectiveness and safety of caspofungin in the treatment of patients with fungal, mainly Candida, infections. The authors concluded that caspofungin is associated with a higher cure rate and fewer adverse effects in comparison with amphotericin B. These conclusions have to be viewed with caution since they are based on few studies with few participants.